[HTML] sciencedirect.com

[HTML][HTML] Population pharmacokinetics analysis and dosing simulations of meropenem in critically ill patients with pulmonary infection

J Lan, Z Wu, X Wang, Y Wang, F Yao, B Zhao… - Journal of …, 2022 - Elsevier
Purpose This study aimed to develop a population pharmacokinetic (PPK) model for
meropenem to optimize dosing regimens for critically ill patients with pulmonary infection …
被引用次数：15 相关文章

Population Pharmacokinetics Analysis and Dosing Simulations Of Meropenem in Critically Ill Patients with Pulmonary Infection

J Lan, Z Wu, X Wang, Y Wang, F Yao… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose This study aimed to develop a population pharmacokinetic (PPK) model for
meropenem to optimize dosing regimens for critically ill patients with pulmonary infection …

Population Pharmacokinetics Analysis and Dosing Simulations Of Meropenem in Critically Ill Patients with Pulmonary Infection.

J Lan, Z Wu, X Wang, Y Wang, F Yao… - Journal of …, 2022 - europepmc.org
Population Pharmacokinetics Analysis and Dosing Simulations Of Meropenem in Critically Ill
Patients with Pulmonary Infection. - Abstract - Europe PMC Sign in | Create an account …
[HTML] jpharmsci.org

[HTML][HTML] Population Pharmacokinetics Analysis and Dosing Simulations Of Meropenem in Critically Ill Patients with Pulmonary Infection

J Lan, Z Wu, X Wang, Y Wang, F Yao… - Journal of …, 2022 - jpharmsci.org
Purpose This study aimed to develop a population pharmacokinetic (PPK) model for
meropenem to optimize dosing regimens for critically ill patients with pulmonary infection …

Population pharmacokinetics analysis and dosing simulations of meropenem in critically ill patients with pulmonary infection.

J Lan, Z Wu, X Wang, Y Wang, F Yao, BX Zhao… - 2022 - cabidigitallibrary.org
Purpose: This study aimed to develop a population pharmacokinetic (PPK) model for
meropenem to optimize dosing regimens for critically ill patients with pulmonary infection …